Related references
Note: Only part of the references are listed.Matrix metalloproteinase-2 and-9 in the sera and in the urine of human oncocytoma and renal cell carcinoma
Angelina Di Carlo
ONCOLOGY REPORTS (2012)
Sensitivity and Specificity of Urinary Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 for the Diagnosis of Renal Cell Carcinoma
Jeremiah J. Morrissey et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma
C. Perrin et al.
PROGRES EN UROLOGIE (2011)
Expressions of Neutrophil Gelatinase-Associated Lipocalin in Gastric Cancer: A Potential Biomarker for Prognosis and an Ancillary Diagnostic Test
Hui-Ju Wang et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2010)
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
Amandine Viau et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib
Camillo Porta et al.
KIDNEY INTERNATIONAL (2010)
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: Correlation with histotype and histological grade
Valeria Barresi et al.
ONCOLOGY REPORTS (2010)
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
Xeni Provatopoulou et al.
BMC CANCER (2009)
Lipocalin2 Expressions Correlate Significantly With Tumor Differentiation in Epithelial Ovarian Cancer
HanByoul Cho et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage
Davide Bolignano et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia
N. Moniaux et al.
BRITISH JOURNAL OF CANCER (2008)
Urinary biomarkers predict brain tumor presence and response to therapy
Edward R. Smith et al.
CLINICAL CANCER RESEARCH (2008)
Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species
Roopali Roy et al.
CLINICAL CANCER RESEARCH (2008)
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
CA Fernández et al.
CLINICAL CANCER RESEARCH (2005)
Biochemical and molecular markers in renal cell carcinoma: an update and future prospects
MK Kashyap et al.
BIOMARKERS (2005)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL) - Modulation of MMP-9 activity by NGAL
L Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
